HCA241220P180000
- 0.00
- 0.000.00%
HCA Healthcare Newsroom
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Optimistic Outlook and Buy Rating for HCA Healthcare Driven by Strategic Initiatives and Market Dynamics
Express News | HCA Healthcare Names Wendy Warren as Senior Vice President and Chief Ethics and Compliance Officer
U.S. Healthcare Spending Climbs 7.5% in 2023
HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 45% Below Their Intrinsic Value Estimate
Fed FOMC Preview: Hawkish Powell Poised to Signal Rate Cuts Are Over
HCA Healthcare Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $319
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Ondine Biomedical to Start Late-stage Trial for Nasal Photodisinfection Technology
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $355
HCA Healthcare Price Target Announced at $380.00/Share by JP Morgan
HCA Healthcare Coverage Assumed by JP Morgan at Neutral
HCA Healthcare Analyst Ratings
HCA Healthcare, Inc.'s (NYSE:HCA) Shares Not Telling The Full Story
Goldman Sachs Adjusts Price Target on HCA Healthcare to $319 From $359, Maintains Neutral Rating
Possible Bearish Signals With HCA Healthcare Insiders Disposing Stock
HCA Healthcare To Go Ex-Dividend On December 13th, 2024 With 0.66 USD Dividend Per Share
December 11th (Eastern Time) - $HCA Healthcare(HCA.US)$ is trading ex-dividend on December 13th, 2024.Shareholders of record on December 13th, 2024 will receive 0.66 USD dividend per share on
3 Sector ETFs & Stocks to Gain On Upbeat November Jobs Data
Here's Why HCA Healthcare (NYSE:HCA) Can Manage Its Debt Responsibly